Drilling Down Into Nielsen Holdings plc (NLSN)

Nielsen Holdings plc (NLSN) is an interesting player in the Technology space, with a focus on Information & Delivery Services. The stock has been active on the tape, currently trading at $36.30, up from yesterday’s close by 0.11%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Nielsen Holdings plc (NLSN) currently trades with a market capitalization of $12.94 Billion. That value represents a market adjusting for revenues that have been growing by 4.52 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $1.27 Billion over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $0.8 on a per share basis this quarter. Perhaps, that suggests something about why 0.58% of the outstanding share supply is held by institutional investors.



Technical Analysis

No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Nielsen Holdings plc recorded a 52-week high of $45.73. It is now trading 9.43% off that level. The stock is trading $36.73 its 50-day moving average by 0.43%. The stock carved out a 52-week low down at $34.22.

In recent action, Nielsen Holdings plc (NLSN) has made a move of -4.30% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 21.04, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 7.98% with $354.66 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of NLSN.

SHARE
Previous articleMedtronic plc (MDT): From Top to Bottom
Next articleThe Case for and Against Array BioPharma Inc. (ARRY)